V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20025162 | 20010690 | null | 92.2 | Adjuvant (A) | 2014-06-30 | 2014-06-30 | FEC 100 + DOCETAXEL | N | null | 20088884 | FEC + DOCETAXEL |
| 20025163 | 20010690 | 1.58 | null | Adjuvant (A) | 2014-01-01 | 2014-02-13 | FEC + DOCETAXEL | N | N | 20088884 | FEC + DOCETAXEL |
| 20025164 | 20010691 | 1.68 | 58.5 | Adjuvant (A) | 2015-01-27 | 2015-01-27 | FEC + DOCETAXEL | 02 | null | 20088892 | FEC + DOCETAXEL |
| 20025165 | 20071230 | 1.64 | null | Adjuvant (A) | 2014-05-07 | 2014-05-19 | FEC + DOCETAXEL | N | N | 20088896 | FEC + DOCETAXEL |
| 20025166 | 20071230 | 1.6 | 73.6 | Neo-adjuvant (N) | 2014-09-01 | 2014-09-19 | FEC + DOCETAXEL | 02 | N | 20088896 | FEC + DOCETAXEL |
| 20025167 | 20010692 | null | 85 | Curative (C) | 2014-01-25 | 2014-01-29 | FEC + DOCETAXEL | 02 | null | 20088901 | FEC + DOCETAXEL |
| 20025168 | 20010692 | 1.53 | 58 | Adjuvant (A) | null | 2014-10-12 | FEC 100 + DOCETAXEL | N | N | 20088901 | FEC + DOCETAXEL |
| 20025169 | 20010692 | 1.64 | 76.2 | Palliative (P) | 2013-10-14 | 2013-10-16 | FEC + DOCETAXEL | 2 | N | 20088901 | FEC + DOCETAXEL |
| 20025170 | 20010692 | 1.62 | 57.5 | Adjuvant (A) | 2014-10-01 | 2014-10-08 | FEC + DOCETAXEL | 02 | null | 20088901 | FEC + DOCETAXEL |
| 20025171 | 20010693 | null | 92 | Neo-adjuvant (N) | 2015-06-21 | 2015-06-26 | FEC + DOCETAXEL | 02 | N | 20088912 | FEC + DOCETAXEL |
| 20025172 | 20071232 | null | 62.3 | Neo-adjuvant (N) | 2016-07-13 | 2016-07-30 | FEC + DOCETAXEL | N | N | 20088913 | FEC + DOCETAXEL |
| 20025173 | 20010694 | 1.65 | null | Adjuvant (A) | 2014-08-28 | 2014-09-12 | FEC + DOCETAXEL | 02 | N | 20088915 | FEC + DOCETAXEL |
| 20025174 | 20010694 | null | null | Adjuvant (A) | 2017-12-19 | 2017-12-30 | FEC 100 + DOCETAXEL | 2 | N | 20088915 | FEC + DOCETAXEL |
| 20025175 | 20010694 | 1.6 | 75 | Adjuvant (A) | 2015-09-22 | 2015-10-11 | FEC + DOCETAXEL | 2 | N | 20088915 | FEC + DOCETAXEL |
| 20025176 | 20010694 | 1.64 | 65 | Adjuvant (A) | 2017-06-24 | 2017-06-27 | FEC + DOCETAXEL | N | N | 20088915 | FEC + DOCETAXEL |
| 20025177 | 20010695 | 1.87 | 78 | Adjuvant (A) | null | 2013-04-27 | FEC 100 + DOCETAXEL | N | N | 20088926 | FEC + DOCETAXEL |
| 20025178 | 20010695 | 1.83 | 68.5 | Not known (9) | 2016-07-14 | 2016-07-15 | FEC + DOCETAXEL | 2 | N | 20088926 | FEC + DOCETAXEL |
| 20025179 | 20010695 | 1.59 | 72.1 | Adjuvant (A) | 2014-03-21 | 2014-04-01 | FEC + DOCETAXEL | 02 | N | 20088926 | FEC + DOCETAXEL |
| 20025180 | 20010696 | null | null | Adjuvant (A) | 2013-03-27 | 2013-04-12 | FEC + DOCETAXEL | N | null | 20088932 | FEC + DOCETAXEL |
| 20025181 | 20010697 | 1.57 | 93.2 | Adjuvant (A) | 2014-11-02 | 2014-11-10 | FEC 100 + DOCETAXEL | 2 | N | 20088933 | FEC + DOCETAXEL |
| 20025182 | 20071235 | 1.61 | 87.2 | null | 2013-10-24 | 2013-11-21 | FEC + DOCETAXEL | 02 | N | 20088938 | FEC + DOCETAXEL |
| 20025183 | 20071235 | null | 70 | Neo-adjuvant (N) | 2017-05-26 | 2017-05-26 | FEC + DOCETAXEL | 02 | N | 20088938 | FEC + DOCETAXEL |
| 20025184 | 20010698 | 1.63 | null | null | 2015-09-26 | 2015-10-08 | FEC + DOCETAXEL | N | N | 20088940 | FEC + DOCETAXEL |
| 20025186 | 20010700 | 1.58 | 69.9 | Neo-adjuvant (N) | 2015-08-17 | 2015-09-03 | FEC + DOCETAXEL | 02 | N | 20088944 | FEC + DOCETAXEL |
| 20025187 | 20010701 | 1.65 | 63.7 | Adjuvant (A) | 2013-12-07 | 2013-12-14 | FEC + DOCETAXEL | N | null | 20088950 | FEC + DOCETAXEL |
| 20025188 | 20071236 | 1.63 | 47.9 | Curative (C) | 2013-12-12 | 2013-12-15 | FEC 100 + DOCETAXEL | 02 | null | 20088951 | FEC + DOCETAXEL |
| 20025189 | 20010702 | 1.59 | 73 | Adjuvant (A) | 2016-11-16 | 2016-11-18 | FEC + DOCETAXEL | 2 | N | 20088953 | FEC + DOCETAXEL |
| 20025190 | 20010702 | 1.61 | null | Adjuvant (A) | 2014-12-17 | 2014-12-25 | FEC 100 + DOCETAXEL | N | N | 20088953 | FEC + DOCETAXEL |
| 20025191 | 20108590 | 1.55 | null | Neo-adjuvant (N) | 2014-01-29 | 2014-02-01 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20088962 | FEC + DOCETAXEL |
| 20025192 | 20010703 | 1.53 | 53.7 | Adjuvant (A) | 2015-12-15 | 2016-01-05 | FEC 60 OR 75 + DOCETAXEL | 02 | N | 20088967 | FEC + DOCETAXEL |
| 20025193 | 20010703 | null | null | Adjuvant (A) | 2017-02-26 | 2017-02-26 | FEC + DOCETAXEL | null | null | 20088967 | FEC + DOCETAXEL |
| 20025194 | 20010703 | 1.73 | 80 | Neo-adjuvant (N) | 2014-08-12 | 2014-08-14 | FEC + DOCETAXEL | 02 | N | 20088967 | FEC + DOCETAXEL |
| 20025195 | 20010704 | 1.68 | 164 | Adjuvant (A) | 2017-02-26 | 2017-03-01 | FEC 100 + DOCETAXEL | 2 | N | 20088975 | FEC + DOCETAXEL |
| 20025196 | 20010705 | 1.61 | 48.7 | Adjuvant (A) | 2017-05-09 | 2017-05-09 | FEC + DOCETAXEL | 02 | null | 20088976 | FEC + DOCETAXEL |
| 20025197 | 20010706 | 1.58 | 73 | Neo-adjuvant (N) | null | 2016-07-11 | FEC 100 + DOCETAXEL | null | null | 20088980 | FEC + DOCETAXEL |
| 20025198 | 20010706 | 1.71 | 112 | Adjuvant (A) | 2017-10-24 | 2017-11-01 | FEC 100 + DOCETAXEL | Y | N | 20088980 | FEC + DOCETAXEL |
| 20025199 | 20010707 | 1.64 | null | Neo-adjuvant (N) | 2014-02-11 | 2014-02-22 | FEC + DOCETAXEL | 02 | N | 20088992 | FEC + DOCETAXEL |
| 20025200 | 20010707 | 1.66 | 100.6 | Adjuvant (A) | 2016-02-28 | 2016-03-09 | FEC 100 + DOCETAXEL | 02 | N | 20088992 | FEC + DOCETAXEL |
| 20025201 | 20010707 | 1.66 | null | Adjuvant (A) | 2015-10-24 | 2015-10-26 | FEC + DOCETAXEL | 2 | null | 20088992 | FEC + DOCETAXEL |
| 20025202 | 20010708 | 1.55 | 62 | Adjuvant (A) | 2017-09-11 | 2017-10-23 | FEC 100 + DOCETAXEL | N | N | 20089003 | FEC + DOCETAXEL |
| 20025203 | 20010708 | 1.71 | null | null | null | 2017-07-10 | FEC + DOCETAXEL | null | null | 20089003 | FEC + DOCETAXEL |
| 20025204 | 20010708 | 1.67 | 81.5 | Adjuvant (A) | 2013-09-04 | 2013-09-24 | FEC + DOCETAXEL | N | N | 20089003 | FEC + DOCETAXEL |
| 20025205 | 20010709 | null | 87.35 | Adjuvant (A) | 2017-03-13 | 2017-03-14 | FEC + DOCETAXEL | 2 | N | 20089014 | FEC + DOCETAXEL |
| 20025206 | 20010710 | 1.79 | 65.8 | Adjuvant (A) | 2017-03-17 | 2017-05-27 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | Y | 20089015 | FEC + DOCETAXEL |
| 20025207 | 20010710 | 1.7 | 72 | Adjuvant (A) | 2015-04-20 | 2015-04-20 | FEC 100 + DOCETAXEL | 02 | N | 20089015 | FEC + DOCETAXEL |
| 20025208 | 20010711 | 1.51 | 111 | Adjuvant (A) | 2015-03-03 | 2015-02-23 | FEC + DOCETAXEL | 02 | N | 20089018 | FEC + DOCETAXEL |
| 20025209 | 20010712 | null | 89.8 | Neo-adjuvant (N) | 2015-08-17 | 2015-09-15 | FEC + DOCETAXEL | N | N | 20089019 | FEC + DOCETAXEL |
| 20025210 | 20071243 | 1.7 | 84.02 | Not known (9) | 2015-03-17 | 2015-03-31 | FEC + DOCETAXEL | 02 | null | 20089021 | FEC + DOCETAXEL |
| 20025211 | 20071243 | 1.6 | 87.15 | Curative (C) | 2014-09-06 | 2014-09-10 | FEC + DOCETAXEL | 02 | N | 20089021 | FEC + DOCETAXEL |
| 20025212 | 20071243 | 1.61 | 49.3 | Adjuvant (A) | 2013-12-28 | 2013-12-29 | FEC + DOCETAXEL | 2 | N | 20089021 | FEC + DOCETAXEL |